OB/GYN Clinical Alert – June 1, 2015
June 1, 2015
View Archives Issues
-
Isotretinoin and Contraception: Should iPLEDGE Be Changed?
In this study of female dermatologic patients, knowledge of the typical effectiveness of contraceptive methods increased after viewing a simple information sheet. Given the teratogenicity of isotretinoin, expanding the use of highly effective contraceptive methods among women of child-bearing potential using this medication is essential.
-
Are We Ready to Give Up the Pap Smear?
A review of the ATHENA trial, which evaluated the prevalence of hrHPV in a large cohort of women and evaluated the most sensitive screening strategy.
-
Mammograms: The Cost of Overdiagnosis
In the United States, the costs associated with the management of false-positive mammograms and breast cancer overdiagnosis is estimated to be $4 billion each year.
-
Macrosomia
Previous Alerts have touched on the relationship between big babies and big problems, such as birth injury, infant/childhood obesity, and diabetes. This special feature is designed to provide a more comprehensive look at the causes, risks, prediction, management, and prevention of macrosomia.